Quest Diagnostics (DGX) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $214.0 million.
- Quest Diagnostics' Income towards Parent Company rose 753.77% to $214.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.0 million, marking a year-over-year increase of 753.77%. This contributed to the annual value of $867.0 million for FY2024, which is 236.13% up from last year.
- Quest Diagnostics' Income towards Parent Company amounted to $214.0 million in Q3 2025, which was up 753.77% from $250.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Income towards Parent Company registered a high of $599.0 million during Q2 2021, and its lowest value of $76.0 million during Q4 2022.
- Over the past 5 years, Quest Diagnostics' median Income towards Parent Company value was $204.0 million (recorded in 2023), while the average stood at $252.5 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 129800.0% in 2021, then tumbled by 7822.35% in 2022.
- Quest Diagnostics' Income towards Parent Company (Quarter) stood at $349.0 million in 2021, then crashed by 78.22% to $76.0 million in 2022, then skyrocketed by 113.16% to $162.0 million in 2023, then increased by 20.99% to $196.0 million in 2024, then rose by 9.18% to $214.0 million in 2025.
- Its Income towards Parent Company was $214.0 million in Q3 2025, compared to $250.0 million in Q2 2025 and $184.0 million in Q1 2025.